Open Letter to Abbott Laboratories

Apr 27 06
From Researchers, Clinicians and AIDS Activist Groups Around the WorldApril 5, 2006 Miles White Chairman and CEO Abbott Laboratories 100 Abbott Park Road Abbott Park, IL 60064Dear Mr. White,We are writing to you to express our concern about the lack of availability in developing countries of the new melt extrusion (Meltrex) formulation of lopinavir/ritonavir (LPV/r), marketed as Kaletra (200/50mg tablets).LPV/r has been recognized as an essential medicine by the WHO1 and will be included in its revised antiretroviral treatment guidelines2, in which boosted protease inhibitors represent the cornerstone of second-line therapy. As you know, the tablet formulation of LPV/r, approved by the US Food and Drug Administration in October 2005, has critically important advantages for patients in developing countries: no dietary restrictions, lower pill burden, and most importantly, storage without refrigeration. Due to the storage requirements of the old formulation, there is the risk that some patients in tropical climates are currently using degraded LPV/r capsules. In short, there is an urgent need in developing countries for access to the new heat-stable formulation of LPV/r, as no other boosted protease inhibitors are practical to use in the hot climates of many of these countries.We urge Abbott to take the following actions to make this crucial second-line option accessible in developing countries:1. Immediately file for registration of the new LPV/r formulation in all countries where the old formulation was registered or pending, as well as in other developing countries.According to the WHO/AMDS registration database3 published in October 2005, the old formulation of LPV/r (133/33.3 mg soft gel capsules) is registered in 55 countries and registration is pending in 13 others, covering 68 of the 69 countries eligible in Abbott's Access Program.4 But the new formulation of the drug has not been registered in any country except for the US. We urge you to immediately file for registration of the new formulation of LPV/r (200/50mg tablets) in developing countries, so that the old formulation can be replaced by the new one, as was done in the US.2. Communicate the countries and the filing dates where registration of the new formulation of LPV/r is pending and a timeline for submissions to remaining countries.We ask that Abbott communicate the countries and the filing dates where registration of the new formulation of LPV/r is pending so that health advocates in these countries can work with national drug regulatory authorities to overcome any delays and provide a timeline for submitting remaining registration requests.3. Publish a price for the new formulation of LPV/r for least-developed and middle-income countries.Since May 2002, Abbott has been selling the old formulation of LPV/r in Africa and Least Developed Countries for $500 per patient per year on an FOB basis (freight, insurance, customs handling, taxes and duties paid by purchaser). Abbott has not yet made public any price for the new formulation of LPV/r in developing countries. We ask that Abbott establish a price that is at least as low as the price for the old formulation in least-developed countries. Abbott's Access Program for the old formulation of LPV/r excludes middle-income countries, resulting in prices up to 12 times more than in least-developed African countries.5 We urge you to make the new formulation available at an affordable price in middle-income countries where millions live on less than US $2 per day.4. Develop a heat-stable formulation of RTV and make it accessible in developing countries.A separate, heat-stable formulation of ritonavir (RTV), marketed as Norvir, is also needed in developing countries so that care-providers can implement the forthcoming WHO guidelines and pair RTV with other available and affordable, heat-stable protease-inhibitors.5. Develop a pediatric formulation of the new formulation of LPV/r.WHO draft pediatric guidelines recommend LPV/r for use in children if there is cold-chain access.6 While this new formulation overcomes the storage challenges presented by the old formulation, care-providers would not be able to cut or crush tablets because the new LPV/r is a coated tablet. Therefore, careproviders need a pediatric version of this formulation so that they can provide adequate second-line regimens for children as well as adults.6. Work with countries to make the new formulation of LPV/r easily available while registration applications are being considered.Because the drug registration process can take months if not years to complete, we ask that Abbott establish a reliable interim system to distribute this new formulation to treatment programs in developing countries while registration is pending.Sincerely,INTERNATIONAL  Stephen Lewis, United Nations Secretary General's Special Envoy for HIV/AIDS in Africa Craig McClure, Executive Director, The International AIDS Society Bianca Kamps, Director, International Dispensary Association (IDA) - HIV/AIDS Group Médecins Sans Frontières / Doctors Without Borders (MSF) European AIDS Treatment GroupUNITED STATES  American Academy of HIV Medicine (AAHIVM) AIDS Treatment Activist Coalition (ATAC) The Drug Development Committee of AIDS Treatment Activist Coalition (ATAC) Elaine J. Abrams, MD, Professor of Pediatrics & Epidemiology, Director, MTCT-Plus, International Center of AIDS Care and Treatment Programs Mailman School of Public Health, Columbia University Lisa Hirschhorn MD MPH, Associate Director, Office of International Programs, Harvard Medical School Division of AIDS Joia S. Mukherjee, MD, MPH, Medical Director, Partners In Health David Hoos, MD, MPH , Director Multicountry Antiretroviral Program (MCAP) Mailman School of Public Health, Columbia University Wafaa El-Sadr, MD, MPH, Columbia University Mark Mirochnick, MD, Associate Professor of Pediatrics, Boston University School of Medicine Ruby Faysey, MD, MPH, Pediatric Clinical Advisor, ICAP, Columbia University School of Public Health Ruth Kuhn, SC, Coordinator Region VI Coalition for Responsible Investment Sisters of Charity of Cincinnati, Corporate Responsibility Committee Lauren Compere, Chair, Interfaith Center on Corporate Responsibility, HIV/AIDS Caucus Chief Administrative Officer/Director of Shareholder Advocacy, Boston Common Asset Management Sister Dolores Bourquin HM, Sisters of the Humility of Mary Cathy Rowan, Corporate Responsibility Coordinator, Maryknoll Sisters Joellen Sbrissa, CSJ, Office of Peace, Justice and Integrity of Creation, Sisters of St. Joseph of La Grange, IL David Scondras, President, Search for a Cure Kevin Outterson, Associate Professor of Law, West Virginia University Foundation for Integrative AIDS Research (FIAR) Gay Men's Health Crisis (GMHC) Global AIDS Alliance (GAA) The Center for AIDS Information & Advocacy Treatment Action Group (TAG) Student Global AIDS Campaign Health Global Access Project (GAP) Health & Development Networks National Jesuit Committee on Investment Responsibility (NJCIR) Universities Allied for Essential Medicines — US and Canada Dominican Sisters of Hope Mercy Investment Program Sisters of Mercy Regional Community of Detroit Ursuline Sisters of Tildonk-U.S. ProvinceARGENTINA  Nexo Salud Iglesia Evangelica Luterana Unida en Argentina y Uruguay, Pasotral Ecumenica, VIH-SIDA, Coordinador Regional Plan de Accion en VIH-SIDA de la Federacion Luterana MundialAUSTRALIA  Professor John Ziegler, MB BS, MD, FRACP, FAAAAI Head, HIV Service, Sydney Children's Hospital, NSW Professor Richard Doherty, Head of Department of Paediatrics, Monash University, and Head of Paediatric Infectious Diseases, Southern Health, VIC Assistant Professor Patricia Price, Snt Lecturer HIV Immunology, University of Western Australia, WA Professor Martyn A French, MB ChB, MD, FRCPath, FRCP, FRACP, Royal Perth Hospital and University of Western Australia, WA Brian Haill, President, The Australian AIDS Fund Incorporated, VIC Dr. David Bradford AM, Sexual Health, Cairns, QLD Dr. Brian Hughes, MBBS, DipSHM, FRACP, FAChSHM, Chair of Education, Australasian Chapter of Sexual Health Medicine Dr. Paul N. Goldwater, BSc, MBBS, FRACP, FRCPA, MASM, Microbiology & Infectious Diseases Department, Women and Children's Hospital, Adelaide, SA Dr. Margaret Gibbons, MBBS, MTH, General Practitioner, Tobwabba Aboriginal Medical Service, NSW Dr. Mark W. Douglas, BSc, MBBS, PhD, FRACP, Infectious Disease Physician Dr. Deborah Couldwell, MBBS, MM, FAChSHM, Staff Specialist Sexual Health Medicine, Parramatta Sexual Health Clinic, NSW Dr. Jeffrey Post, Infectious Diseases Physician, The Prince of Wales Hospital NSW Dr. Marisa Gilles, KPHU Broome, WA Mark Bebbington, Policy and International Manager, Australian Federation of AIDS Organisations, Inc. Newtown, NSW L. Dorgogna, Clinical Immunology and Biochemical Genetics, Royal Perth Hospital, WA Karen Blyth CNC, Victorian HIV Consultancy, The Alfred, Melbourne, VIC Pam Price, HIV Women's Health Statewide, Adelaide, SA Amanda Chambers, STD Services, Royal Adelaide Hospital, SA Scott Parker, Harm Minimisation Coordinator, We Help Ourselves (WHOS), Redfern, NSW Mark Kelly, Senior Medical Officer, AIDS Medical Unit, Brisbane, QLD Mark Beltchev, Nurse Manager, HIV Unit, The Alfred, Melbourne, VICAUSTRIAGottfried Mernyi, Managing Director, Protestant Association for World Mission Sonja Hauser, Assoc. AIDS Life, Production Anton Mair, Head of Dept. for Evaluation, Development Policy and Strategies, Federal Ministry of Foreign Affairs Birgit Habermann, Coordinating Committee for Development Issues (KEF) at the Academy of Sciences Dr. Florian Breitenecker, General Practioner, Detention Centre Josefstadt Stephan Neuhäuser, International Research Cooperation, Federal Ministry for Education, Science and Culture Dr. Norbert Kohrgruber (MD), Medical University of Vienna, Dr. Angela Öllinger, Dermatologist/Spezialist HIV/Aids, General Hospital Linz (AKH) Dr. Harald Schopper, Head of the Detention Centre Josefstadt Univ. Prof. Dr. Christoph Wenisch, President of the Austrian Society of Infectious Diseases, Kaiser Franz Josef Hospital Dr. N. Vetter, Head of the Lung Dept. Otto-Wagner Hospital Dr. Andrea Steuer, Otto-Wagner Hospital Dr. Brigitte Schmied, Otto-Wagner Hospital Dr. Wolfgang Steflitsch, Otto-Wagner Hospital Dr. Heinrich Haber, Otto-Wagner Hospital Dr. Manfred Gartner, Otto-Wagner Hospital Dr. Gunvor Koitz, Otto-Wagner Hospital Dr. Herbert Keller, Otto-Wagner Hospital Dr. Wolfgang Scholz, Otto-Wagner Hospital Dr. Alexander Aichelburg, Otto-Wagner Hospital Dr. Maria Geit, General Hospital Linz Dr. Armin Reiger, Head of HIV/AIDS Department, General Hospital Vienna (AKH) Julia Göd, Chairwoman, Association ONGHALO — Future for Africa Jakob Krisper, Vice Chairman, Association ONGHALO — Future for Africa Markus Fux, Board Member, Association ONGHALO — Future for Africa Bernhard Hlawati, Board Member, Association ONGHALO — Future for AfricaBELGIUMDirk Pyck, Directeur, Sensoa (Dutch speaking platform of AIDS NGOs) Professor Robert Colebunders, Medical Tropical Institute, Antwerpen Mr. Thierry Martin, Director, Prevention SIDABRAZILGESTOS - Soropositividade, Comunicação e Gênero ABIA - Associação Brasileira Interdisciplinar de AIDS CONECTAS Direitos Humanos Grupo Pela Vidda São Paulo DAWN Brasil GAPA/São Paulo GAPA/ RS LACCASO - Consejo Latinoamericano y del Caribe de ONGs con Servicio en VIH/SIDA GIV — Grupo de Inventivo à VidaCAMBODIADr. Juian Elliot, MD, Technical Advisor for HIV Treatment and Care, Phnom Penh Dr. Sarah Huffam, Technical Advisor for HIV Treatment and Care, Phnom PenhCANADACanadian HIV/AIDS Legal Network Canadian AIDS Society Interagency Coalition on AIDS and Development (ICAD) Canadian Harm Reduction Network Oxfam Canada Dignitas International Canadian Crossroads International RESULTS Canada SIDA/AIDS Moncton Inc. Dr. Noah Novogrodsky Dr. Joel Lexchin, Associate Professor, School of Health Policy and Management, York University Dr. Jill Claire Cohen Bonnie Gray, Canadian Support of Rural African Initiatives (CSRAI)CHINAYiming Shao, M.D., Ph.D., Chief Expert on AIDS, Chinese Center for Disease Control and Prevention (China CDC), National Center for AIDS/STD Control and Prevention (NCAIDS), China CDC, Director, Division of Research on Virology and Immunology, NCAIDS, Chairman, Committee on Virology, Chinese Society for Microbiology Odilon Couzin, Executive Director, China AIDS Info FuJie Zhang, MD, Director, Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention Director, National HIV/AIDS Clinical Task Force Thomas, Executive Director, AIDS Care ChinaDENMARKNina Friss-Moleer, MD, PhD, Clinical Research Associate, Copenhagen HIV Programme, Hvidovre University Hospital Sören Thybo, MD, MSc, Consultant, Department of Infectious Diseases, RigshospitaletECUADORDarío Abarca, Ecuadorian Coalition of PLWHAEL SLAVADORAsociación AtlacatFRANCEPr. Eric Delaporte, UMR 145 L'Institut de recherche pour le developpement (IRD)/ Université de Montpellier Pr. Laurent Mandelbrot, Hôpital Louis Mourier Pr. Jean-Michel Molina, Chef de Service, Maladies Infectieuses, Hôpital Saint Louis Dr. Suna Balkan, Service de Maladies Infectieuses, Hôpital Saint Louis Dr. Jean-Baptiste Guiard Schmidt, Service des Maladies Infectieuses et Tropicales, Hôpital Tenon Pr. Patrick Yeni, Chef de Service, Maladies Infectieuses, Hôpital Bichat Dr. François Bourdillon, Président de la Société de Santé Publique Pr. François Dabis, Unité INSERM 593, Institut de Santé Publique, Epidémiologie et Développement (ISPED) Dr. Xavier Anglare, ISPED Dr. Catherine Seyler, ISPED Dr. Christine Danel, ISPED Dr. Besigin Tonwe-Gold, ISPED Dr. Valériane Leroy, ISPED Dr. Elise Klement, Service de Maladies Infectieuses, Hôpital Pitié-Salpêtrière Dr. Julie Veraspuech, Bordeaux Eric Fleutelot, Head of International Programs, Sidaction, TRT-5 Act Up-Paris Act Up-ToulouseGERMANYAlbert Petersen, Chair of the Ecumenical Pharmaceutical Network Nairobi Dr. med Günther Schmutz, Arzt für Innere Medizin, Haematologie und Internistische Onkologie, HIVSchwerpunktpraxis Dr. med. Stefan Esser, Leiter der HIV-Ambulanz am Universitatsklinikum Essen, Klinik für Dermatologie und Venerologie Bernd Pastors, Managing Director and Member of the Board, German Medical Organization, Action Medeor Prof. Dr. Schlomor Staszewski, HIVCENTER, Klinikum der Johann Wolfgang Goethe- Universität Frankfurt am Main Medizinische Klinik III Dr. med. Tessa Lennemann, HIVCENTER Klinikum der Johann Wolfgang Goethe- Universität Frankfurt am Main Medizinische Klinik III Dr. med. Heiko Jessen, HIV-Schwerpunktpraxis Dr. med. Heribert Knechten, 1. Vorstandsvorsitzender, Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung HIV-Infizierter e.V. (DAGNÄ e.V.) Dr. med. Peter Hartmann, Arzt, Praxis mit HIV Schwerunkt Netzwerk der Therapieaktivisten, c/o Projekt Information e.V. Dr. Luis Carlos Escobar Pinzón, Bundesgeschäftsführer, Deutsche AIDS-Hilfe e.V Dr. med. Albrecht Ulmer, Gemeinschaftspraxis Dr. med. Andreas Carganico, Facharzt für Allgemeinmedizin, Gemeinschaftspraxis Dr. med. Ansgar Rieke, Arzt für Innere Medizin / Nephrologie / Infektiologie (DGI), Immunologische Ambulanz, II. Medizinische Klinik, Klinikum Kemperhof, Koblenz Dr. med. Bernd Buchholz, HIV-Ambulanz der Universitätsklinik Mannheim Dr. med. Christoph Mayr, Arzt, Praxis MVZ Ã„rzteforum Seestrasse Dr. med. Gundula Notheis, Oberärztin und Leiterin der Immundefekt-Ambulanz Dr. von Haunerschen Kinderspital Dr. med. Hans Jäger, Gemeinschaftspraxis München Dr. med. Holger Flick, DTMPH, Arzt, Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie Charité Universitätsmedizin Dr. med. Jan-Peter Siedentopf, Infektionsambulanz, Klinik für Geburtsmedizin, Campus Virchow- Klinikum, Charité — Universitätsklinikum Dr. med. Jörg Gölz, Praxiszentrum Kaiserdamm Berlin Dr. med. Katharina von Weizsäcker, Infektionsambulanz, Klinik für Geburtsmedizin, Campus Virchow- Klinikum, Charité — Universitätsklinikum Dr. Rainward Bastian, Director, German Institute for Medical Mission (DIfÃ„M) Olaf Hirschmann, MPH, Advisor HIV/AIDS in Development Policy, Brot für die Welt, Diakonisches Werk der EKD P.D. Dr. med. Keikawus Arastéh, Direktor der Klinik für Innere Medizin Infektiologie / Gastroenterologie, Vivantes Auguste-Viktoria-Klinikum Prof. Dr. med. Gerd Fätkenheuer, Klinik I für Innere Medizin, Klinische Infektiologie Universitätsklinikum Prof. Dr. med. Hartwig Klinker, Leiter des Schwerpunktes Infektiologie, Medizinische Klinik und Poliklinik II Klinikum der Universität Prof. Dr. med. Jürgen Lohmeyer, Infektiologie-Ambulanz Universitätsklinikum, GieÃŸen Prof. Dr. med. Norbert Suttorp, Director, Charité-Universitätsmedizin Berlin Department of, Infectious Diseases Marwin Meier, Co-ordinator HIV and AIDS, World Vision GermanyGREECEChrisoula Botsi, MD, 'Andreas Sigros' Hospital Hadjichristodoulou Christos,MD,PhD, Ass.Professor of Epidemiology and Infectious Diseases, Medical School of Larissa, University of Larissa Antonios Vasiloyiannakopoulos,MD,PhD, Head of 1st Infectious Diseases Department, 'Erricos Dunant' Hospital, Vice President of the Hellenic Association of Tropical,Geographical and Travelling Medicine Sophia Kourkoudi, MD, Internal Medicine, Infectious Diseases Department, "Andreas Sigros" Hospital, Athens Kirsten Loio, MD, Internal Medicine, Infectious Diseases Department, "Andreas Sigros" Hospital, Athens Andreas Grilias, MD Hellenic Association for Protection of People with Hemophilia Gatsiou Hariklea,MD, Internal Medicine, 'Erricos Dunant' Hospital Koutsouri Natassa,MD, Internal Medicine, 'Erricos Dunant' Hospital Kirpoglou Panagiotis,MD, Internal Medicine, 'Erricos Dunant' Hospital Amanatidou Konstantina,MD, Internal Medicine, 'Erricos Dunant' Hospital Rapti Rena ,MD, Internal Medicine, 'Erricos Dunant' Hospital Dimou Evangelini,MD, Internal Medicine, 'Erricos Dunant' Hospital Kanelopoulos Petros,MD,PhD, Internal Medicine, 'Erricos Dunant' Hospital Vassilopoulou Adamantia,MD, Internal Medicine, 'Erricos Dunant' Hospital Palamarou Christina,MD, Internal Medicine, 'Erricos Dunant' Hospital Sevastianos Vassilios,MD, Internal Medicine, 'Erricos Dunant' Hospital Peros Ioannis, MD,PhD, Dermatologist, 'Erricos Dunant' Hospital Hellenic Association of Tropical,Geographical and Travelling Medicine ACT UP Hellas Greek Committee of Feeding Minds,Fighting Hunger Igisipolis, Club for Dialogue and Activism Hellenic Branch of Feminist net Antigoni: European Watch Against Racism and Xenophobia Helen Choremi-Papadopoulou, MD, Ass. Professor of Athens University, Director of the Immunology- Compatibility Department, General Hospital "Laiko"HONG KONGDr. Kath Reynolds, BMedSci, MBBS, FRACGP, MPH, Trop Med, Central Hong KongICELANDAlbert Adalsteinsson, HIV+ Group IcelandITALYItalian League for Fighting AIDS (LILA) Action Aid International Amref Italia Lila Cedius onlus Acra Cooperiamo lo Sviluppo Ricerca e Cooperazione Osservatorio Italiano sull'Azione Globale contro l'AIDS Professor Fredy Suter, Primario U.O. Malattie Infettive, OO.RR. Bergamo Anna Siniscalchi, Dipartimento di Medicina Clinica e Sperimentale, Sezione di Farmacologia, Università di Ferrara Daniele Dionisio, Coordinatore "Access to drugs: International Policies" CLIA, Italia e Direttore della Divisione di Malattie Infettive dell'Ospedale di Pistoia Emanuele Nicastri, Dipartimento di Epidemiologia, Istituto Nazionale Malattie Infettive Lazzaro Spallanzani Mauro Moroni, UniversitÃ  di Milano, Luigi Sacco — Milano Anna Danise, Infectious Diseases, Milano Maurizio Bonati, Istituto Mario Negri Gianni Tognoni, Istituto Mario Negri Silvio Garattini, Presidente, Istituto Mario Negri Alberto Castagnola, Economista, Presidente Formin Giovanna Melandri, Parlamentare, Commissione Affari Esteri, Camera dei Deputati Walter Veltroni, Sindaco di Roma Luciano Vecchi, Parlamentare Vittorio Agnoletto, Europarlamentare, Gruppo GUE, Sinistra Unitaria Europea Francesco Martone, Parlamentare, Commissione Affari Esteri e Migrazione Senato della Repubblica Luigi Malabarba, Parlamentare, Senato della Repubblica Anna Donati, Parlamentare, Senato della Repubblica Tommaso Sodano, Parlamentare, Senato della Repubblica Alberto Michelini, Parlamentare, Esperto per il Piano di Azione G8 per l'Africa Luisa Morgantini, Europarlamentare, Presidente Commissione Sviluppo Umberto Guidoni, Europarlamentare, Gruppo GUE, Sinistra Unitaria Europea Dott. Caterina Uberti-Foppa, MD, Infectious Diseases Clinic, HSR Milano Dr. Massimo Cernuschi, Medico Infettivologo, Centro San Luigi di Milano, Presidente, Associazione SolidarietÃ  AIDS, Milano Adriano Lazzarin, Director, Clinic of Infectious Diseases of San Raffaele Scientific Institute Alessandro Soria, Clinic of Infectious Diseases, Vita-Salute Univeristy, San Raffaele Scientific Institute Elena Seminari, MD, San Raffaele Scientific Institute Giovanna Travi, MD, Department of Infectious Disease, San Raffaele Institute Dr.sa Ratti Deborah, MD, Department of Infectious Disease, San Raffaele HospitalIRAN  Persia+ISRAELGideaon Hirsh, MD, Executive Director, Israel AIDS Task ForceJAPANNaomi Wakasugi MD., PhD., Professor, Graduate School of Political Science, WASEDA University Takashi Sawada, MD, Vice Chair Person, Services for the Health in Asian African Regions (SHARE)LATVIAAleksandrs Molokovskis, Board Chair, Association HIV. LV AGIHAS (PLWHA Support Group)THE NETHERLANDSMarcel van Soest, Executive Director, World AIDS Campaign Sjoera Dikkers,Director, Stop AIDS Now! Mauro Guarinieri, Global Network of People living with HIV/AIDS (GNP+) Peter Heintze, Director, The Evert Vermeer StichtingNICARAGUAAsociación Nicaraguense de Personas Vivendo con VIH y SIDANORWAYDr. Andy Oxman, Senior Research, Norwegian Knowledge Center for the Health Services Dr. John-Arne Røttingen MD PhD MSc, Director General, Norwegian Knowledge Center for the Health Services Berit Mørland, DDS, PhD, Deputy Director, Norwegian Knowledge Center for the Health Services President, HTA-International Johan Bruun MD PhD, Professor, Senior Consultant Infectious Diseases, Ulleval University Hospital Oystein Anders Strand MD PhD, Senior Consultant, Infectious Diseases, Akershus University HospitalPERUAsociación Lazos de VidaSOUTH AFRICASipho Mthathi, General Secretary, Treatment Action Campaign Prof. Andy Gray, Centre for the AIDS Programme of Research in South Africa (CAPRISA) Dr Douglas Wilson, Department of Medicine, Edendale Hospital, University of KwaZuluNatal Dr Andrew Boulle, Infectious Diseases Epidemiology unit, University of Cape Town Dr Elma de Vries, Rural Doctors Association of South Africa (RuDASA) Artists for a New South AfricaSPAINJose Gatell MD, Infectious Diseases and HIV Unit, Hospital Clinic Barcelona, Vice President European HIV Society Elena Valenciano, Member of the EU Parliament Francisca Pleguezuelos, Member of the EU Parliament Miguel Angel Martínez, Member of the EU Parliament Carles Campuzano I Canades, Member of EU Parliament Jose Javier Sanchez Espinosa, Red Cross Robert Acquet, Service Comptabilité, Bayer Crop Science SA Lyon Tenemos SIDA GobalSIDA A+MAS Anesvad Acción contra el SIDA IAVI Fundación Ecología y desarrollo Fundación Triángulo Más+Madrid RED 2002 Save the Children World Aids Campaign FarmamundiSWEDENPer Björkman, M.D. Ph.D, Dept. Of Infectious Diseases, Malmoe University Hospital Eric Sandström MD, PhD, Professor, Department of Infectious Diseases, Karolinska University Hospital Sven Britton, Professor, Center for Infectious Medicine, Department of Medicine, Karolinska InstitutetSWITZERLANDBernard Hirschel, Division des Maladies Infectieuses, Unité VIH/SIDA Hôpital Universitaire de Genève Alexandra Calmy, MD, Research Fellow, Geneva University Hospital Julien Reinhard, Déclaration de Berne Sepp Gähwiler, CEO, Bethlehem Mission Immensee Gerhard Bärtschi , CEO, TearFund Switzerland Andreas Loebell, Terre des Hommes Pharmaciens Sans Frontières Ecumenical Advocacy AllianceTHAILANDPraphan Phanuphak MD, Professor of Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University; and Director of HIV Netherlands Australia Thailand, Thai Red Cross AIDS Research Centre Kiat Ruxrungtham, M.D., Associate Professor of Medicine, Head, Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, Chulalongkorn University; and Deputy Director of HIV Netherlands Australia Thailand, Thai Red Cross AIDS Research Centre Jintanat Ananworanich MD, Chief, South East Asia Research with Hawaii (SEARCH) Consultant, The HIV Netherlands, Australia, Thailand Research Collaboration (HIV-NAT) Chris Duncombe MD, Senior Staff Physician, The HIV Netherlands, Australia, Thailand Research Collaboration (HIV-NAT) Somsit Tansupsawadikul MD, Senior Physician, Bamrasnaradura Hospital Kulkanya Chokephaibulkit MD, Senior Pediatrician, Department of Paediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University Nirun Vanprapar MD, Pediatrician, Department of Paediatrics, Faculty of Medecine, Siriraj Hospital Keswadee Lapphra MD, Pediatrician, Department of Paediatrics, Faculty of Medecine, Siriraj Hospital Ploenchan Chetchotisakd MD, Professor of Medicine, Department of Medicine, Faculty of Medicine, Khon Kaen University Pope Kosalaraksa, MD, Associate Professor of Paediatrics, Department of Paediatrics, Faculty of Medicine, Khon Kaen University Pranee Moungnoi MD, Consultant Psychiatrist, Department of Child and Adolescent Psychiatry, Institute of Child Health Manop Srisuphanthavorn MD, Chief Medical Officer, Bangkwang Central Prison Witaya Petdachai MD, Hospital Deputy Director and Head of Paediatrics, Phrachomklao Hospital Chureeratna Bowonwatanauwong, MD, Senior Physician, Chonburi Regional Hospital Noppadon Sereerat MD, Director, Kuchinarai Royal Crown Prince Hospital, Kuchinarai, Kalasin Jon Ungphakorn, Senator and member of Public Health Committee, The Senate, Parliament House Sureerat Thimakkra, Representative, National Economic and Social Advisory Council Vithaya Kulsomboon PhD, MPHM, Chair of Social Pharmacy Department , Faculty of Pharmaceutical Sciences, Chulalongkorn University Niyada Kiatying-Angsulee, Ph.D, Faculty of Pharmaceutical Sciences, Chulalongkorn University Jiraporn Limpananont, Faculty of Pharmaceutical Sciences, Chulalongkorn University Sumlee Jaidee, Asst. Professor, Faculty of Pharmaceutical Sciences, Chulalongkorn University Kamon Uppakaew, Chairman, Thai Network for People With HIV/AIDS Nimit Tienudom, Director, AIDS Access Foundation Paisan Suwannawong, Director, Thai AIDS Treatment Action Group (TTAG) Karyn Kaplan, Director, Policy and Development, Thai AIDS Treatment Action Group (TTAG)UNITED KINGDOMChristian Aid International Planned Parenthood Federation DHIVERSE The UWESO (Uganda Women's Effort to Save Orphans) UK Trust National AIDS Trust International HIV/AIDS Alliance UK Coalition of People Living with HIV and AIDS Dr. Ed Wilkins, Specialist in HIV/AIDS and WHO Consultant, North Manchester Hospital Fiona Pettitt, International Community of Women living with HIV/AIDS (ICW)VENEZUELAACCSI - Acción Ciudadana Contra el SIDAFOOTNOTES1 14th edition, WHO Model List of Essential Medicines (revised March 2005) 2 Complete guidelines for adults and adolescents are forthcoming. A preliminary summary is available for consultation at http://www.who.int/3by5/mediacentre/news51/en/ 3 http://ftp.who.int/htm/AMDS/drugsdatabase.pdf (LPV/r is not listed as registered or pending in Eritrea which is eligible for Abbott's Access Program) 4 http://www.accesstohivcare.org/en/partners/countries.aspx 5 Doctors Without Borders/Médecins Sans Frontières Briefing Note, "Abbott's New and Improved Kaletra: Only in the US," February 2006 6 http://www.who.int/hiv/pub/guidelines/PaedARTguideDRAFT_webreviewNOV05%20_2_.pdf